1. Home
  2. BDL vs ITRM Comparison

BDL vs ITRM Comparison

Compare BDL & ITRM Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.

  • Machine Learning Prediction
  • ML Decision
  • BDL
  • ITRM
  • Stock Information
  • Founded
  • BDL 1959
  • ITRM 2015
  • Country
  • BDL United States
  • ITRM Ireland
  • Employees
  • BDL N/A
  • ITRM N/A
  • Industry
  • BDL Restaurants
  • ITRM Biotechnology: Pharmaceutical Preparations
  • Sector
  • BDL Consumer Discretionary
  • ITRM Health Care
  • Exchange
  • BDL Nasdaq
  • ITRM Nasdaq
  • Market Cap
  • BDL 48.0M
  • ITRM 49.5M
  • IPO Year
  • BDL N/A
  • ITRM 2018
  • Fundamental
  • Price
  • BDL $24.01
  • ITRM $1.75
  • Analyst Decision
  • BDL
  • ITRM Strong Buy
  • Analyst Count
  • BDL 0
  • ITRM 1
  • Target Price
  • BDL N/A
  • ITRM $5.00
  • AVG Volume (30 Days)
  • BDL 2.3K
  • ITRM 1.6M
  • Earning Date
  • BDL 02-11-2025
  • ITRM 11-14-2024
  • Dividend Yield
  • BDL 2.05%
  • ITRM N/A
  • EPS Growth
  • BDL N/A
  • ITRM N/A
  • EPS
  • BDL 1.64
  • ITRM N/A
  • Revenue
  • BDL $185,457,000.00
  • ITRM N/A
  • Revenue This Year
  • BDL N/A
  • ITRM N/A
  • Revenue Next Year
  • BDL N/A
  • ITRM N/A
  • P/E Ratio
  • BDL $14.89
  • ITRM N/A
  • Revenue Growth
  • BDL 8.71
  • ITRM N/A
  • 52 Week Low
  • BDL $23.94
  • ITRM $0.81
  • 52 Week High
  • BDL $29.72
  • ITRM $3.02
  • Technical
  • Relative Strength Index (RSI)
  • BDL 35.83
  • ITRM 45.98
  • Support Level
  • BDL $23.94
  • ITRM $1.78
  • Resistance Level
  • BDL $25.25
  • ITRM $1.95
  • Average True Range (ATR)
  • BDL 0.28
  • ITRM 0.30
  • MACD
  • BDL -0.03
  • ITRM -0.10
  • Stochastic Oscillator
  • BDL 4.49
  • ITRM 0.00

About BDL Flanigan's Enterprises Inc.

Flanigan'S Enterprises Inc operates as a chain of small cocktail lounges and packages liquor stores throughout South Florida. Its menu consists of a wide variety of options including prime rib, steaks, pasta, entree salads, burgers, a variety of sandwiches, and oversized signature desserts. The business activity is principally conducted in two segments namely Restaurant and Package liquor store segment. Its Restaurant segment offers alcoholic beverages and full food service and Package stores consist of retail liquor sales and related items. The company generates maximum revenue from Restaurant segment.

About ITRM Iterum Therapeutics plc

Iterum Therapeutics PLC is a clinical-stage pharmaceutical company. The company is engaged in developing and commercializing sulopenem to be the first and only oral and intravenous branded penem available globally. Its sulopenem program has the potential to offer a solution to the problem of antibiotic resistance and the toxicity limitations of existing agents. The company operates as a single business segment, which is the development and commercialization of treatments for drug-resistant bacterial infections.

Share on Social Networks: